Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
39
days
Ambient air emissions of endocrine-disrupting metals and the incidence of hormone receptor- and HER2-dependent female breast cancer in USA
AuthorsEsther Ro; Vivian Vu; Yudan Wei
Affiliations1. MD Program, Mercer University School of Medicine, Macon, USA; 2. Department of Internal Medicine at Atrium Health Carolinas Medical Center, Charlotte, USA; 3. Department of Community Medicine, Mercer University School of Medicine, Macon, USA
11
days
How to ensure uninterrupted treatment of radiotherapy patients during delta variants of SARS-CoV-2 virus epidemic: the latest experience from Xi’an, China
AuthorsYongkai Lu; Ruijuan Chen; Yi Li
Affiliations1. Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China; 2. Xi’an Central Hospital, The Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
37
days
In-vitro analysis on the potential use of dental pulp mesenchymal stem cells on arecoline-induced oral epithelial cells
AuthorsArchana A. Gupta; Supriya Kheur; Saranya Varadarajan; Chandini Rajkumar; Vikrant R. Patil
Affiliations1. Department of Oral Pathology and Microbiology, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India; 2. Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India; 3. Department of Oral Pathology and Microbiology, Sathyabama Dental College and Hospital, Chennai, India; 4. Biogenre Private Limited, Pune, India
77
days
Innovation in cancer therapeutics and regulatory perspectives
AuthorsPinky Sharma; Vikas Jhawat; Pooja Mathur; Rohit Dutt
Affiliations1. School of Medical and Allied Sciences, GD Goenka University, Gurugram, India
117
days
DNA methylation marker to estimate ovarian cancer cell fraction
AuthorsTakahiro Ebata; Satoshi Yamashita; Hideyuki Takeshima; Hiroshi Yoshida; Yoshiko Kawata; Nao Kino; Toshiharu Yasugi; Yasuhisa Terao; Kan Yonemori; Tomoyasu Kato; Toshikazu Ushijima
Affiliations1. Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan; 2. Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan; 3. Department of Gynecology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan; 4. Department of Obstetrics and Gynecology, Juntendo University, Tokyo, Japan; 5. Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; 6. Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan
121
days
Forward to a methodological proposal to support cancer patients: the dialogics’ contribution for the precision care
AuthorsEleonora Pinto; Rita Alfieri; Luisa Orrù; Marta Silvia Dalla Riva; Gian Piero Turchi
Affiliations1. Unit of Surgical Oncology of the Esophagus and Digestive Tract, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy; 2. Department of Philosophy, Sociology, Pedagogy and Applied Psychology, University of Padua, Padua, Italy
23
days
Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth
AuthorsKanako Yokomizo; Kayoko Waki; Miyako Ozawa; Keiko Yamamoto; Sachiko Ogasawara; Hirohisa Yano; Akira Yamada
Affiliations1. Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan; 2. Department of Pathology, Kurume University School of Medicine, Kurume, Japan
26
days
Effects of metformin on human bone-derived mesenchymal stromal cell—breast cancer cell line interactions
AuthorsMaryana Teufelsbauer; Clemens Lang; Adelina Plangger; Barbara Rath; Doris Moser; Clement Staud; Christine Radtke; Christoph Neumayer; Gerhard Hamilton
Affiliations1. Department of Plastic and Reconstructive Surgery, Medical University of Vienna, Vienna, Austria; 2. Department of Trauma Surgery, Sozialmedizinisches Zentrum Ost, Donauspital, Vienna, Austria; 3. Institute of Pharmacology, Medical University of Vienna, Vienna, Austria; 4. Department of Cranio, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria; 5. Department of Vascular Surgery, Medical University of Vienna, Vienna, Austria
54
days
ERCC6L is a biomarker and therapeutic target for non–small cell lung adenocarcinoma
AuthorsGuoxin Hou; Zhimin Lu; Yanyu Bi; Jingjing Deng; Xinmei Yang
Affiliations1. Department of Oncology, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, China; 2. Department of Outpatient, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, China; 3. Department of Respiratory, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, China
73
days
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
AuthorsHua Zhang; Jintong Chen; Mingyue Zhang; Munan Zhao; Luyao Zhang; Bin Liu; Siqing Wang
Affiliations1. Department of Gastrointestinal Surgery, The First Hospital of Jilin University, Changchun, China; 2. Department of Cancer Immunology, The First Hospital of Jilin University, Changchun, China; 3. Department of Gynecological Oncology, The First Hospital of Jilin University, Changchun, China; 4. Department of Cancer Center, The First Hospital of Jilin University, Changchun, China; 5. Department of Hand and Foot Surgery, The First Hospital of Jilin University, Changchun, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days